X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cancer (11) 11
chemotherapy (10) 10
index medicus (10) 10
humans (8) 8
aged (6) 6
female (6) 6
male (6) 6
middle aged (6) 6
metastasis (5) 5
oncology (5) 5
aged, 80 and over (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
care and treatment (4) 4
clinical trials (4) 4
colorectal cancer (4) 4
fluorouracil - therapeutic use (4) 4
trial (4) 4
5-fluorouracil (3) 3
adult (3) 3
analysis (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
leucovorin - therapeutic use (3) 3
life sciences (3) 3
medical prognosis (3) 3
open-label (3) 3
oxaliplatin (3) 3
product development (3) 3
prospective studies (3) 3
quality-of-life (3) 3
surgery (3) 3
survival (3) 3
usage (3) 3
aged patients (2) 2
bevacizumab (2) 2
cancer patients (2) 2
cancer therapies (2) 2
capecitabine (2) 2
carcinoma, squamous cell - drug therapy (2) 2
carcinoma, squamous cell - secondary (2) 2
cisplatin (2) 2
clinical-trials (2) 2
colorectal-cancer (2) 2
disease-free survival (2) 2
drug therapy (2) 2
esophageal cancer (2) 2
fluorouracil - administration & dosage (2) 2
france - epidemiology (2) 2
gastroenterology & hepatology (2) 2
irinotecan (2) 2
medicine & public health (2) 2
metastases (2) 2
observational study (2) 2
quality of life (2) 2
radiation therapy (2) 2
radiotherapy (2) 2
rectal cancer (2) 2
treatment outcome (2) 2
18f-fluorodihydroxyphenylalanine (1) 1
1st progression (1) 1
1st-line therapy (1) 1
[ sdv.spee ] life sciences [q-bio]/santé publique et épidémiologie (1) 1
[sdv.can]life sciences [q-bio]/cancer (1) 1
abridged index medicus (1) 1
adenocarcinoma (1) 1
adjuvant chemotherapy (1) 1
adult patients (1) 1
advanced (1) 1
advanced gastric cancer (1) 1
age factors (1) 1
albumin (1) 1
anal carcinoma (1) 1
and chemotherapy (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
anti-ulcer agents - adverse effects (1) 1
antibiotics (1) 1
antigenic determinants (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
anus (1) 1
anus neoplasms - drug therapy (1) 1
anus neoplasms - pathology (1) 1
apoptosis (1) 1
area under curve (1) 1
atrial septum (1) 1
bevacizumab - therapeutic use (1) 1
beyond progression (1) 1
biosimilar (1) 1
biosimilar pharmaceuticals - administration & dosage (1) 1
biosimilar pharmaceuticals - adverse effects (1) 1
body mass index (1) 1
bone metastasis (1) 1
bone neoplasms - secondary (1) 1
camptothecin - analogs & derivatives (1) 1
camptothecin - therapeutic use (1) 1
carcinoid heart disease (1) 1
carcinoma, squamous cell - pathology (1) 1
cardiovascular disease (1) 1
cell biology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


WORLD JOURNAL OF GASTROENTEROLOGY, ISSN 1007-9327, 08/2019, Volume 25, Issue 29, pp. 4007 - 4018
BACKGROUND Anti-epidermal growth factor receptor therapy is associated with skin adverse events not previously reported with conventional chemotherapy.... 
FACTOR RECEPTOR INHIBITORS | RASH | Panitumumab | Skin toxicity | PHASE-II | EGFR | Quality of life | TRIAL | IMPACT | THERAPY | IRINOTECAN | QUALITY-OF-LIFE | GASTROENTEROLOGY & HEPATOLOGY | Epidermal growth factor receptor inhibitors | Metastatic colorectal cancer | Observational Study
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e15014 - e15014
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 05/2016, Volume 24, Issue 5, p. 1991
Chemotherapy-induced neutropenia is a serious and potentially life-threatening consequence of cancer treatment. Prophylactic treatment with granulocyte-colony... 
Women | Usage | Safety regulations | Oncology, Experimental | Research | Complications and side effects | Chemotherapy | Antibiotics | Granulocyte colony-stimulating factor | Lymphomas | Drug therapy | Health aspects | Cancer | Neutropenia
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2015, Volume 33, Issue 3_suppl, pp. 661 - 661
661 Background: In the randomized phase 3 VELOUR trial, aflibercept + FOLFIRI demonstrated a statistically significant overall survival benefit compared with... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 305 - 314
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2014, Volume 32, Issue 3_suppl, pp. 95 - 95
95 Background: There is little evidence that chemotherapy (CT) impacts on outcome of patients with MSEC. We designed an ongoing randomized phase 2 trial to... 
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 25, pp. 2395 - 2406
Journal Article
Supportive Care in Cancer, ISSN 0941-4355, 5/2016, Volume 24, Issue 5, pp. 1991 - 1998
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2018, Volume 36, Issue 18_suppl, pp. LBA4001 - LBA4001
LBA4001 Background: FOLFIRINOX is more effective than gem as first-line treatment in metastatic pancreatic cancer for patients (pts) with good performance... 
Journal Article
BMC Cancer, ISSN 1471-2407, 08/2017, Volume 17, Issue 1, pp. 574 - 8
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2017, Volume 35, Issue 4_suppl, pp. 94 - 94
94 Background: Trastuzumab in combination with platinum-based chemotherapy is the standard first line regimen in HER2 positive advanced gastric cancer.... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.